|
|
|
International Clinical Trials
|
Acceleration of the integration of mobile health (mHealth) technologies into clinical trial operations is expected to be the catalyst for the adoption of disruptive research platforms with capabilities to overcome barriers in both clinically mature and emerging markets. While mHealth applications of smart devices, wearable biometric sensors, and telemedicine enable health monitoring, data collection, and patient communications have been around for some time. Despite this, their widespread use in clinical research should still be considered in its infancy. We continue to see the fast development of integrated mHealth platforms that have the potential to turn the traditional research model on its head – taking studies to patients rather than bringing patients into site-based studies. Powered by Big Data and connected across patients, researchers, and caregivers, emerging mHealth platforms will expand research participation, reduce costs, and integrate research with treatment in new models of personalised medicine based on real-world evidence.
The mHealth Disruption Four foundational trends are driving 21st century biomedical research:
- Globalisation is expanding drug development into the emerging markets of Africa, Asia, and Latin America
- Big Data is being harnessed to understand disease impacts at the population level and support evidence-based medical practice
- Real-world evaluation is extending the continuum from traditional randomised clinical trials to new research models that assess real-world outcomes
- Personalised medicine is advancing with targeted therapies tailored to smaller populations and the growth of patientcentric research
|
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
News and Press Releases |
 |
Manufacturing Consultancy up 150% as Life Sciences prepare for a digital future
Zenith Technologies, a world leader in delivering manufacturing software
solutions to the life sciences industry, has seen a 150% rise in demand
for its consultancy arm services.
More info >> |
|
 |
White Papers |
 |
|
Running Better Trials Taking an Intelligent Monitoring Approach
Bioclinica
When it comes to implementing a risk-based monitoring program, it is not
just about reducing monitoring visits and doing less Source Document
Verification (SDV). It’s about bringing together your people, a solid
process, and the right technology to run a better trial.
Success
with risk-based monitoring requires the ability to make sense of the
thousands, if not millions, of data points captured by multiple
disparate sources in a clinical trial. With the sheer volume of data
generated on a daily basis comes complexity. How does one make sense of
it all? Information overload burdens even the most experienced study
teams who struggle to understand which data matters most and what it
means.
More info >> |
|
 |
Industry Events |
 |
Respiratory Drug Delivery (RDD®) Europe 2019
7-10 May 2019, Estoril Congress Center, Lisbon
Respiratory
Drug Delivery (RDD®) Europe 2019 connects emerging and high-level scientists, academics,
industrial and regulatory specialists, and clinicians. It is a must-attend conference
for companies involved in research, development, testing or marketing of
medicines, devices and services associated with pulmonary or nasal pharmaceutical
products. This year, RDD Europe 2019 will be held in Estoril (Lisbon),
Portugal, May 7-10, 2019, and, as in previous years is jointly organized by RDD
Online and Aptar Pharma.
More info >> |
|
|
